Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Director departure
Appointed director
Asset disposition
Credit agrmnt [a]
SURMODICS INC (SRDX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/02/2023 8-K Quarterly results
07/26/2023 8-K Quarterly results
06/08/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SURMODICS, SUBLIME, POUNCE, SURVEIL, SUNDANCE, AVESS, TELEMARK, SERENE"
05/25/2023 SD Form SD - Specialized disclosure report:
04/26/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/06/2023 SC 13G/A BlackRock Inc. reports a 7.2% stake in SURMODICS INC
03/28/2023 8-K Quarterly results
03/20/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
03/15/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SURMODICS, SUBLIME, POUNCE, SURVEIL, SUNDANCE, AVESS, TELEMARK, SERENE"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 8-K Quarterly results
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/10/2023 SC 13G/A Trigran Investments, Inc. reports a 16.5% stake in SURMODICS, INC.
02/10/2023 SC 13G/A TRIGRAN INVESTMENTS LP reports a 5% stake in SURMODICS, INC.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 7% stake in Surmodics Inc.
02/06/2023 10-Q Quarterly Report for the period ended December 31, 2022
02/06/2023 8-K Quarterly results
02/03/2023 8-K Quarterly results
01/23/2023 SC 13G/A BlackRock Inc. reports a 16.4% stake in SURMODICS INC
01/19/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SURMODICS, INC. 8-K",
"Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon"
12/19/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
12/19/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
11/23/2022 10-K Annual Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
10/17/2022 8-K Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Ob...
Docs: "Credit, Security and Guaranty Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Holdings, LLC, Surmodics Coatings, LLC, SurModics MD, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., and Surmodics MD Operations, LLC, as borrowers, the guarantors from time to time party thereto, MidCap Funding IV Trust and MidCap Financial Trust and the lenders from time to time party thereto (excluding schedules and exhibits which Surmodics, Inc. agrees to furnish to the Securities and Exchange Commission upon request and certain personal information)",
"Credit, Security and Guaranty Agreement by and among Surmodics, Inc., Surmodics Shared Services, LLC, Surmodics Holdings, LLC, Surmodics Coatings, LLC, SurModics MD, LLC, Surmodics Coatings Mfg, LLC, Surmodics IVD, Inc., NorMedix, Inc., and Surmodics MD Operations, LLC, as borrowers, the guarantors from time to time party thereto, MidCap Funding IV Trust and MidCap Financial Trust and the lenders from time to time party thereto (excluding schedules and exhibits which Surmodics, Inc. agrees to furnish to the Securities and Exchange Commission upon request and certain personal information)"
09/02/2022 SC 13G Soleus Capital Master Fund, L.P. reports a 5.1% stake in Surmodics, Inc.
08/31/2022 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "SURMODICS, INC. 8-K"
07/27/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/27/2022 8-K Quarterly results
05/27/2022 SD Form SD - Specialized disclosure report:
05/17/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
05/17/2022 SC 13G TRIGRAN INVESTMENTS LP reports a 5% stake in SURMODICS, INC.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy